Navigation Links
AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007
Date:2/28/2008

Positive cash flow from operations achieved for Q4 and the year

BOSTON, Feb. 28 /PRNewswire-FirstCall/ -- AMICAS, Inc. (Nasdaq: AMCS), a leader in radiology and medical image and information management solutions, today reported unaudited financial results for the fourth quarter and year ended December 31, 2007.
(Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO )

Q4 Financial Highlights

Revenue: Total revenues for the fourth quarter of 2007 were $11.7 million compared to $11.4 million for the fourth quarter of 2006.

Operating Income/Loss: Operating loss for the fourth quarter of 2007 was $1.9 million compared to operating loss of $2.1 million for the fourth quarter of 2006.

Net Income/Loss: The Company's net loss from continuing operations for the fourth quarter of 2007 was $902,000 or $(0.02) per share, compared to net loss from continuing operations of $1.1 million or $(0.03) per share, for the fourth quarter of 2006.

In the fourth quarter of 2007, both operating loss and net loss from continuing operations included a $0.3 million charge related to the elimination of the chief operating officer position, $0.3 million of non-cash stock-based compensation expense, and $0.8 million of depreciation and amortization. In the fourth quarter of 2006, operating loss and net loss from continuing operations included $0.4 million of non-cash stock-based compensation expense and $0.8 million for depreciation and amortization.

Cash and Cash Flow: AMICAS ended the fourth quarter of 2007 with a cash, cash equivalents, and marketable securities balance of $75.6 million, no long- term debt, and work
'/>"/>

SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call
2. AMICAS to Present at UBS Global Healthcare Services Conference
3. MedQuest Standardizes on AMICAS Vision Series PACS
4. AMICAS Solutions Closing the Loop in Radiology Communications
5. AMICAS Transforms Critical Results Notification with RadStream
6. AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow
7. Webcast Alert: AMICAS, Inc. Announces 3rd Quarter 2007 Earnings Conference Call
8. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
9. AMICAS Schedules Third Quarter Earnings Call
10. AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference
11. AMICAS Hosts Complimentary DRA Education Session Featuring Timothy Trysla

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...RESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNewswire/ ...2001 and have expanded over the years serving the ...cility which was originally set up in an area of 2...ices, as part of the suite of services by Max Neem...s a valuable offering. ,, The pharmacy inventor...
(Date:12/1/2009)...SHINGTON, Dec. 1 Indivi...more likely than those with traditional coverage t... be more engaged in wellness programs, and to be m...tter in holding down costs, according to survey re...enefit Research Institute (EBRI). ,, At the sa...
(Date:12/1/2009)...ORT LAUDERDALE, Fla., Dec. 1 Orbus...rollment in the randomized clinical trial of the C... Stent). ,, A prospective, randomized, multicen...of an ablu M inal sirolimus coat ED bio- E ...p to 20 sites in Asia, Australia, Europe and South...
(Date:12/1/2009)...ients in California are unable to successfully obt...hospitals despite recent state legislation intende...w study. , Posing as low-income uninsured patien... than one-third of the hospitals they approached a...han those allowed under California law, according ...
(Date:12/1/2009)... Lumension announces general availabilit...e to deliver end-to-end endpoint management capabi... management console architecture. , ... -- Lumension, a global leader in endpoint managem...n® Endpoint Management and Security Suite (LEM...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6
... Children,s Hospital UCLA have found that low-dose...the overall quality of life for adolescents suffer...he syndrome affects 6 percent of middle school stu... is the first of its kind to look at the effects o...
... In times of economic,uncertainty, engaging emplo...same time, becomes much more challenging. Engaged ...nization that employs them and that, in,turn, tran...ts into activities that drive employee engagement ...
...cial Guidance for Fiscal 2008 through 2010, PITTS...oday that it will host a conference call and live ...provide a review of the first,quarter ended March ...rck Generics, which the company acquired on,Oct. 2...
... A brand leader notes, "We make,decisions for the...." Brand,decisions must be made at the right time,...ximize the value of a brand., Brand Management ha...ore -- but that is fraught with potential,pitfalls...
...Illinois Residents to Say it out loud, CHICAGO, M...is residents is experiencing a mental health chall...ign was launched today to promote,good mental heal...lt in Illinois, lower the barriers that prevent pe...
...ION, WASHINGTON, May 1 The following media,advis...er(s):, Peter I. Buerhaus, PhD, RN, FAAN, Profess...inary Health Workforce Studies, Vanderbilt,Univers...th Ulrich, EdD, RN, FACHE, FAAN, Senior Vice Presi...
Other Medicine News:Health News:Antidepressant found to alleviate symptoms of irritable bowel syndrome in adolescents 2Health News:Complimentary Excerpt of Employee Engagement: Programs and Activities that Work Available from Best Practices 2Health News:Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008 2Health News:Best Practices in Designing Effective Brand Teams 2Health News:Making It Easier to Talk About Mental Health 2Health News:Making It Easier to Talk About Mental Health 3Health News:Making It Easier to Talk About Mental Health 4Health News:Will Nursing Shortage Cripple Future Health Care Plans? 2
(Date:12/1/2009)..., , TAI,AN, China, Dec. 1 /PR...s, Inc. (OTC Bulletin Board: CBPO) (Nasdaq: CBPO ... leading plasma-based biopharmaceutical companies ...eived approval to list its,common stock on the NAS...ts its shares to begin trading on the NASDAQ on,We...
(Date:12/1/2009)..., , BEIJING, Dec. 1 /PRNewswire...eading provider of biopharmaceutical products in C...rth purchase order for its H1N1 vaccine, PANFLU.1(...tion Technology for the national,purchase plan. Un...oduce an,additional one million doses of PANFLU.1 ...
(Date:12/1/2009)..., , ROCKVILLE, Md., Dec. 1 /PRNewswire-Fi...NDA ) announced today that the waiting period has ...t Improvements Act of 1976 with respect to Vanda,s...Pharma AG, and that the agreement is now effective...ting effectiveness of the agreement, triggers an u...
Breaking Medicine Technology:China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Light at the speed of a bicycle and much more 56500 1Light at the speed of a bicycle and much more 56500 2Sinapis Pharma Announces Frederick Frank as Consultant 56499 1Sinapis Pharma Announces Frederick Frank as Consultant 56499 2Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 1Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 2
...rum Institut (SSI) and Intercell, report promisi...h a tuberculosis (TB) subunit vaccine , , »...ains Intercell’s,adjuvant IC31™ , , ...y the European Union aims to,either , repla...uo;Calmette vaccine” or,to , boost it...
... 15, 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) to...n a novel nucleotide analog, GS 9219, which has sh...l studies, at the,2007 Annual Meeting of the Ameri...will take place in Los Angeles on April 14-18, 200...ly focused on,oncology, GS 9219 emerged from our e...
Other Medicine Technology:Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 2Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 3Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 4Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219,to be Presented at AACR 2Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219,to be Presented at AACR 3
Continuous Flow Cystoscopes
Prolieve™ Thermodilatation System
The Prostatron® System
...Targis® System uses Cooled ThermoTherapy® ... to deliver precisely targeted microwave energy de...ulative necrosis for durable clinical outcomes. Du...urethral and rectal temperatures for optimal thera...
Medicine Products: